Author: xnewsline

Noninvasive Toolkit for MASH: Metabolic Dysfunction–Associated Steatohepatitis Assessment and Management

Metabolic dysfunction–associated steatohepatitis (MASH) is an increasingly recognized progressive liver disease characterized by hepatic steatosis (fat accumulation) with inflammatory injury and hepatocellular ballooning, typically arising in the setting of metabolic dysregulation. The clinical challenge is that MASH often coexists with obesity, insulin…Read More »